Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. META
5. ACN
6. NVDA
7. IBM
8. PRIM
9. SPY
10. PFE

Go back to Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome

Denali Therapeutics Inc. (DNLI) PT Lowered to $22 at Stifel

May 8, 2024 6:17 AM EDT

Stifel analyst Paul Mattels lowered the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $22.00 (from $26.00) while maintaining a Hold rating.

The analyst comments "Most importantly, DNLI is noting now that CDER "may be open to discussing an accelerated path" for... More